State Street’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,143,739
Closed -$31M 3834
2019
Q4
$31M Buy
5,143,739
+642,125
+14% +$3.87M ﹤0.01% 1837
2019
Q3
$16.2M Sell
4,501,614
-1,172,149
-21% -$4.22M ﹤0.01% 2191
2019
Q2
$15.2M Sell
5,673,763
-521,259
-8% -$1.4M ﹤0.01% 2278
2019
Q1
$18.3M Buy
6,195,022
+1,221,045
+25% +$3.61M ﹤0.01% 2101
2018
Q4
$7.91M Buy
4,973,977
+160,408
+3% +$255K ﹤0.01% 2533
2018
Q3
$17.7M Sell
4,813,569
-1,213,670
-20% -$4.47M ﹤0.01% 2257
2018
Q2
$17.1M Buy
6,027,239
+109,374
+2% +$310K ﹤0.01% 2235
2018
Q1
$22M Buy
5,917,865
+202,991
+4% +$753K ﹤0.01% 1992
2017
Q4
$16.5M Buy
5,714,874
+1,354,991
+31% +$3.9M ﹤0.01% 2182
2017
Q3
$19.6M Buy
4,359,883
+385,454
+10% +$1.73M ﹤0.01% 2046
2017
Q2
$18.2M Sell
3,974,429
-342,787
-8% -$1.57M ﹤0.01% 2046
2017
Q1
$18.2M Sell
4,317,216
-803,944
-16% -$3.38M ﹤0.01% 2017
2016
Q4
$21.2M Buy
5,121,160
+1,465,723
+40% +$6.05M ﹤0.01% 1853
2016
Q3
$29.6M Buy
3,655,437
+646,882
+22% +$5.24M ﹤0.01% 1509
2016
Q2
$23.5M Sell
3,008,555
-719,112
-19% -$5.61M ﹤0.01% 1643
2016
Q1
$28.8M Sell
3,727,667
-416,344
-10% -$3.21M ﹤0.01% 1475
2015
Q4
$44.7M Sell
4,144,011
-856,518
-17% -$9.24M ﹤0.01% 1231
2015
Q3
$34.6M Buy
5,000,529
+25,026
+0.5% +$173K ﹤0.01% 1377
2015
Q2
$44.1M Buy
4,975,503
+1,217,690
+32% +$10.8M ﹤0.01% 1346
2015
Q1
$37.1M Buy
3,757,813
+918,910
+32% +$9.06M ﹤0.01% 1411
2014
Q4
$34.8M Buy
2,838,903
+31,154
+1% +$382K ﹤0.01% 1420
2014
Q3
$28M Buy
2,807,749
+1,245,222
+80% +$12.4M ﹤0.01% 1498
2014
Q2
$11.8M Sell
1,562,527
-5,322,902
-77% -$40.3M ﹤0.01% 2151
2014
Q1
$22.7M Buy
6,885,429
+724,557
+12% +$2.38M ﹤0.01% 1686
2013
Q4
$20.5M Buy
6,160,872
+1,968,372
+47% +$6.54M ﹤0.01% 1729
2013
Q3
$12.7M Buy
4,192,500
+883,143
+27% +$2.67M ﹤0.01% 1997
2013
Q2
$27.1M Buy
+3,309,357
New +$27.1M ﹤0.01% 1451